Adalimumab-adbm Injection, an Interchangeable Biosimilar to Humira, Now Available

Adalimumab-adbm injection, a biosimilar to Humira (adalimumab), has been made available by Boehringer Ingelheim.

Related Keywords

Boehringer Ingelheim ,Stephen Pagnotta ,Executive Director ,Biosimilar Commercial Lead ,